go to contents

THT BIOMATERIALS GmbH

Back to list

Facts

Founded
2020
Staff
3
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Focus
consumables / reagents

Profile

THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components (https://tht-biomaterials.com).

R&D:In vitro toxicoty, in vitro diagnostics (cancer)/drug development. Bioaktive tissue-ink. 2D coating/3D gel. Organoids. Filler and wound healing.

Production:HUMAN PLACENTA Collagen-I, liquid or freece-dried. HUMAN PLACENTA Laminin-111. HUMAN PLACENTA Substrate (hpS).

Similar companies in RDM biotech/pharma

HG Pharma GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health / animal health
Details

Lactosan GmbH

Organization type
RDM biotech/pharma
Region
Styria
Focus
industrial processing
Details

Origimm Biotechnology GmbH, a Sanofi company

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

ChironWells GmbH

Organization type
RDM biotech/pharma
Region
Tyrol
Focus
human health
Details

Contact

Dr.-Bohr-Gasse 7
1030 Wien
Vienna

Contact: Johannes Hackethal (CTO)
Email: office@tht-biomaterials.com
Website